The bioequivalence of liquid and freeze-dried formulations of recombinant human chorionic gonadotrophin

Current Medical Research and Opinion

Volumn 20, Issue 3, 2004, Pages 397-402

  Van Der Merwe, R ^a   Lugan, Isabelle ^b   Lecuelle, H ^b   Papasouliotis, O ^b   Buraglio, M ^b  

^a Bourn Hall Clinic ^*  (United Kingdom)

^b Serono International SA   (Switzerland)

Author keywords

Assisted reproduction therapies; Bioequivalence; Freeze dried; Liquid; Pharmacokinetics; Recombinant human chorionic gonadotrophin

Indexed keywords

CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT CHORIONIC GONADOTROPIN;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; DRUG UTILIZATION; DYSMENORRHEA; EMOTIONAL DISORDER; FEMALE; FREEZE DRYING; HEADACHE; HUMAN; HUMAN EXPERIMENT; INFERTILITY THERAPY; INJECTION SITE; LIQUID; LOW BACK PAIN; MALE; MOUTH ULCER; NAUSEA; NORMAL HUMAN; OPEN STUDY; OVARY FOLLICLE MATURATION; PARAMETER; PHARMACOKINETICS; PHASE 1 CLINICAL TRIAL; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; SKIN BLEEDING;

ADULT; BIOLOGICAL AVAILABILITY; CHORIONIC GONADOTROPIN; CROSS-OVER STUDIES; DOSAGE FORMS; FEMALE; FREEZE DRYING; HUMANS; MALE; PHARMACEUTICAL SOLUTIONS; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME;

EID: 1542510896     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904125003044     Document Type: Conference Paper

References (10)

1. Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Ann Rev Biochem 1981;50:465-95
2. Gemzell C. Induction of ovulation with human gonadotropins. Recent Prog Horm Res 1965;21:179-204
3. Ludwig M, Doody KJ, Doody KM. Use of recombinant human chorionic gonadotropin in ovulation induction. Fertil Steril 2003;79:1051-9
4. Albano C, Smitz J, Camus M, Bennink HC, Van Steirteghem AC, Devroey P. Pregnancy and birth in an in-vitro fertilization cycle after controlled ovarian stimulation in a woman with a history of allergic reaction to human menopausal gonadotrophin. Hum Reprod 1996;11:1632-4
5. Whitman-Elia GF, Banks K, O'Dea LS. Recombinant follicle-stimulating hormone in a patient hypersensitive to urinary-derived gonadotropins. Gynecol Endocrinol 1998;12:209-12
6. Fonjallaz P, Loumaye E. Recombinant hCG (Ovidrel) and recombinant interferon-betala (Rebif). J Biotechnol 2001;87:279-81
7. Driebergen R, Baer G. Quantification of follicle stimulating hormone (follitropin alfa): is in vivo bioassay still relevant in the recombinant age? Curr Med Res Opin 2003;19:41-6
8. European Recombinant Human Chorionic Gonadotrophin Study Group. Induction of final follicular maturation and early luteinization in women undergoing ovulation Induction for assisted reproduction treatment - recombinant HCG versus urinary HCG. Hum Reprod 2000;15:1446-51
9. Driscoll GL, Tyler JP, Hangan JT, Fisher PR, Birdsall MA, Knight DC. A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation. Hum Reprod 2000;15:1305-10
10. Chang P, Kenley S, Burns T, Denton G, Currie K, DeVane G, et al. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertil Steril 2001;76:67-74